University Hospital

Medicine & Life Sciences

1. Neoplasms 100%
2. Japan 89%
3. Non-Small Cell Lung Carcinoma 83%
4. Therapeutics 74%
5. Lung 55%
6. Drug Therapy 54%
7. Lung Neoplasms 53%
8. Survival 47%
9. Recurrence 44%
10. Neoplasm Metastasis 43%
11. Mutation 43%
12. Breast Neoplasms 42%
13. Tomography 39%
14. Kidney 39%
15. Tibial Meniscus 37%
16. Lung Transplantation 34%
17. Serum 33%
18. ErbB Receptors 33%
19. Cisplatin 33%
20. Genes 32%
21. Hepatocellular Carcinoma 31%
22. Bone and Bones 31%
23. Radiofrequency Ablation 31%
24. Retrospective Studies 29%
25. Transplants 27%
26. Confidence Intervals 27%
27. Safety 26%
28. Living Donors 26%
29. Prostatic Neoplasms 26%
30. Stomach Neoplasms 26%
31. Liver 26%
32. Cell Line 26%
33. Small Cell Lung Carcinoma 25%
34. Magnetic Resonance Imaging 25%
35. Liver Transplantation 24%
36. Gefitinib 24%
37. Biopsy 24%
38. Carcinoma 24%
39. Prospective Studies 23%
40. Multicenter Studies 22%
41. Cohort Studies 22%
42. Incidence 22%
43. Pediatrics 21%
44. Adenoviridae 20%
45. Tooth 20%
46. Chemoradiotherapy 20%
47. Radiotherapy 20%
48. Stomach 20%
49. Lymph Nodes 20%
50. Diabetic Nephropathies 19%
51. Wounds and Injuries 19%
52. Tears 19%
53. Odds Ratio 19%
54. Child 18%
55. Progression-Free Survival 18%
56. Proteins 18%
57. Apoptosis 18%
58. Stents 17%
59. Hemorrhage 17%
60. Systematic Reviews 17%
61. Biomarkers 17%
62. Squamous Cell Carcinoma 17%
63. Messenger RNA 17%
64. Seizures 17%
65. Colorectal Neoplasms 17%
66. Randomized Controlled Trials 16%
67. Atrial Heart Septal Defects 16%
68. Urinary Bladder Neoplasms 16%
69. Elderly 16%
70. Stroke 16%
71. Aneurysm 16%
72. Docetaxel 16%
73. Eye 15%
74. Pharmaceutical Preparations 15%
75. Hematopoietic Stem Cell Transplantation 15%
76. Brain 15%
77. Tissue Donors 15%
78. Protein-Tyrosine Kinases 15%
79. Esophageal Neoplasms 15%
80. Knee 15%
81. Thorax 15%
82. Survival Rate 15%
83. Renal Cell Carcinoma 15%
84. Pancreatic Neoplasms 15%
85. Endoscopic Mucosal Resection 15%
86. Cytokines 15%
87. Observational Studies 14%
88. Infections 14%
89. Growth 14%
90. Gene Expression 14%
91. Skin 14%
92. Meta-Analysis 14%
93. Electroencephalography 14%
94. Adenocarcinoma of Lung 14%
95. Inflammation 14%
96. In Vitro Techniques 14%
97. Injections 13%
98. Antibodies 13%
99. Lymphoma 13%
100. Pathologic Constriction 13%